Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Voysey M. et al, (2021), The Lancet, 397, 99 - 111

Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial

Folegatti PM. et al, (2020), The Lancet, 396, 467 - 478

Use of gene expression studies to investigate the human immunological response to malaria infection

Hodgson SH. et al, (2019), Malaria Journal, 18

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children

Tiono AB. et al, (2018), PLOS ONE, 13, e0208328 - e0208328

Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposure

Abdi AI. et al, (2017), BMC Infectious Diseases, 17

Role of Activins in Hepcidin Regulation during Malaria

Spottiswoode N. et al, (2017), Infection and Immunity, 85

Assessment of the Plasmodium falciparum Preerythrocytic Antigen UIS3 as a Potential Candidate for a Malaria Vaccine

Longley RJ. et al, (2017), Infection and Immunity, 85

Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants

Bliss CM. et al, (2017), Molecular Therapy, 25, 547 - 559

Changes in Serological Immunology Measures in UK and Kenyan Adults Post-controlled Human Malaria Infection

Hodgson SH. et al, (2016), Frontiers in Microbiology, 7

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants

Afolabi MO. et al, (2016), Molecular Therapy, 24, 1470 - 1477

Demonstration of the Blood-StagePlasmodium falciparumControlled Human Malaria Infection Model to Assess Efficacy of theP. falciparumApical Membrane Antigen 1 Vaccine, FMP2.1/AS01

Payne RO. et al, (2016), Journal of Infectious Diseases, 213, 1743 - 1751

Malaria: fluid therapy in severe disease.

Hodgson SH. and Angus BJ., (2016), BMJ clinical evidence, 2016

Lessons learnt from the first controlled human malaria infection study conducted in Nairobi, Kenya

Hodgson SH. et al, (2015), Malaria Journal, 14

Standardization of the antibody-dependent respiratory burst assay with human neutrophils and Plasmodium falciparum malaria

Llewellyn D. et al, (2015), Scientific Reports, 5

Assessment of FMP2.1/AS01B, an asexual blood-stage malaria vaccine, in a phase I/II a clinical trial using blood-stage controlled human malaria infection

Payne RO. et al, (2015), TROPICAL MEDICINE & INTERNATIONAL HEALTH, 20, 22 - 22

Prime-boost vaccination with chimpanzee adenovirus and modified vaccinia Ankara encoding TRAP provides partial protection againstPlasmodium falciparuminfection in Kenyan adults

Ogwang C. et al, (2015), Science Translational Medicine, 7, 286re5 - 286re5

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

Hodgson SH. et al, (2015), Journal of Infectious Diseases, 211, 1076 - 1086

Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies

Hodgson SH. et al, (2015), Malaria Journal, 14, 33 - 33

A Phase Ia Study to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 CS Administered Alone and with MVA CS

de Barra E. et al, (2014), PLoS ONE, 9, e115161 - e115161

Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection

Hodgson SH. et al, (2014), Frontiers in Microbiology, 5

Load More

Include forthcoming?